Oppenheimer & Co’s Omnicell OMCL Stock Holding History

Oppenheimer & Co’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-21,778	Closed	-$820K	–	1493
2023 Q4	$820K	Buy	21,778 +10,377	+91%	+$382K	0.02%	778
2023 Q3	$514K	Buy	+11,401	New	+$691K	0.01%	934
2015 Q3	–	Sell	-8,000	Closed	-$302K	–	1428
2015 Q2	$302K	Sell	8,000 -5,900	-42%	-$215K	0.01%	1088
2015 Q1	$488K	Sell	13,900 -1,000	-7%	-$33K	0.01%	877
2014 Q4	$493K	Buy	+14,900	New	+$460K	0.01%	826
2013 Q4	–	Sell	-16,001	Closed	-$379K	–	1436
2013 Q3	$379K	Buy	+16,001	New	+$357K	0.01%	878

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Oppenheimer & Co's OMCL Position: Q1 2024 in Review

Oppenheimer & Co sold out of Omnicell (OMCL) in Q1 2024, closing a stake of 21,778 shares — an estimated $820K sold.

Oppenheimer & Co first reported a position in OMCL in Q3 2013 and held it in 6 quarters. The position peaked at $820K in Q4 2023. 266 funds tracked by Wall St. Rank hold OMCL as of Q1 2024.

Oppenheimer & Co reported no remaining Omnicell position as of Q1 2024 after selling out during the quarter.
Oppenheimer & Co sold 21,778 Omnicell shares in Q1 2024, an estimated $820K.
Oppenheimer & Co first reported a position in Omnicell in Q3 2013 and held it in 6 quarters.
Oppenheimer & Co's Omnicell position peaked at $820K in Q4 2023.
266 funds tracked by Wall St. Rank held Omnicell as of Q1 2024.

Based on Oppenheimer & Co's 13F filing for Q1 2024, filed 7 May 2024.